Sanda MG - Search Results

1

Expanded prostate cancer index composite for clinical practice: development and validation of a practical health related quality of life instrument for use in the routine clinical care of patients with prostate cancer.

Chang P, Szymanski KM, Dunn RL, Chipman JJ, Litwin MS, Nguyen PL, Sweeney CJ, Cook R, Wagner AA, DeWolf WC, Bubley GJ, Funches R, Aronovitz JA, Wei JT, Sanda MG. Chang P, et al. Among authors: sanda mg. J Urol. 2011 Sep;186(3):865-72. doi: 10.1016/j.juro.2011.04.085. Epub 2011 Jul 23. J Urol. 2011. PMID: 21788038 Free PMC article.

2

Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy.

Partin AW, Piantadosi S, Sanda MG, Epstein JI, Marshall FF, Mohler JL, Brendler CB, Walsh PC, Simons JW. Partin AW, et al. Among authors: sanda mg. Urology. 1995 May;45(5):831-8. doi: 10.1016/S0090-4295(99)80091-0. Urology. 1995. PMID: 7538245

3

Clinical and biological characteristics of familial benign prostatic hyperplasia.

Sanda MG, Doehring CB, Binkowitz B, Beaty TH, Partin AW, Hale E, Stoner E, Walsh PC. Sanda MG, et al. J Urol. 1997 Mar;157(3):876-9. J Urol. 1997. PMID: 9072590

4

Longitudinal cohort analysis of lethal prostate cancer progression in transgenic mice.

Hsu CX, Ross BD, Chrisp CE, Derrow SZ, Charles LG, Pienta KJ, Greenberg NM, Zeng Z, Sanda MG. Hsu CX, et al. Among authors: sanda mg. J Urol. 1998 Oct;160(4):1500-5. J Urol. 1998. PMID: 9751403

5

Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancer.

Sanda MG, Smith DC, Charles LG, Hwang C, Pienta KJ, Schlom J, Milenic D, Panicali D, Montie JE. Sanda MG, et al. Urology. 1999 Feb;53(2):260-6. doi: 10.1016/s0090-4295(98)00539-1. Urology. 1999. PMID: 9933036

6

Early castration reduces prostatic carcinogenesis in transgenic mice.

Eng MH, Charles LG, Ross BD, Chrisp CE, Pienta KJ, Greenberg NM, Hsu CX, Sanda MG. Eng MH, et al. Among authors: sanda mg. Urology. 1999 Dec;54(6):1112-9. doi: 10.1016/s0090-4295(99)00297-6. Urology. 1999. PMID: 10604719

7

Bladder neck-sparing modification of radical prostatectomy adversely affects surgical margins in pathologic T3a prostate cancer.

Marcovich R, Wojno KJ, Wei JT, Rubin MA, Montie JE, Sanda MG. Marcovich R, et al. Among authors: sanda mg. Urology. 2000 Jun;55(6):904-8. doi: 10.1016/s0090-4295(00)00451-9. Urology. 2000. PMID: 10840106

8

Antitumor efficacy of tumor-antigen-encoding recombinant poxvirus immunization in Dunning rat prostate cancer: implications for clinical genetic vaccine development.

Charles LG, Xie YC, Restifo NP, Roessler B, Sanda MG. Charles LG, et al. Among authors: sanda mg. World J Urol. 2000 Apr;18(2):136-42. doi: 10.1007/s003450050186. World J Urol. 2000. PMID: 10854149 Free PMC article.

9

Prospective assessment of patient reported urinary continence after radical prostatectomy.

Wei JT, Dunn RL, Marcovich R, Montie JE, Sanda MG. Wei JT, et al. Among authors: sanda mg. J Urol. 2000 Sep;164(3 Pt 1):744-8. doi: 10.1097/00005392-200009010-00029. J Urol. 2000. PMID: 10953138

10

Benign prostatic glands at surgical margins of radical prostatectomy specimens: frequency and associated risk factors.

Shah R, Bassily N, Wei J, Mucci NR, Montie JE, Sanda MG, Rubin MA. Shah R, et al. Among authors: sanda mg. Urology. 2000 Nov 1;56(5):721-5. doi: 10.1016/s0090-4295(00)00775-5. Urology. 2000. PMID: 11068287

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

218 results

Search Page

Filters